FILTER
FILTERED INTERVIEW RESULTS
Maria Eugenia Parot
GENERAL MANAGER, GOLDER ASSOCIATES
Golder Associates discuss their business in Chile.
Bart Doyle
GENERAL MANAGER, MAINSTREAM RENEWABLE POWER CHILE
Mainstream Renewable Power are at the forefront of Chile’s dramatic increase in renewable energy production.
Matthew Hogan & Kumar Arunachalam
CHAIRMAN & CEO, VENUS METALS
Venus Metals has a varied portfolio of different mineral deposits and is currently concentrating on meeting growing demand for the minerals required by batteries.
Jamie Lyons
OWNER, ATLAS DRILLING
Atlas Drilling is prepared for an increase in activity in British Columbia.
John Williamson
PRESIDENT AND CEO, ALTIPLANO MINERALS
Altiplano is developing projects in Chile where it intends to use their cashflow to expand further.
Darko Louit Nevistic
EXECUTIVE VICE PRESIDENT, KOMATSU CUMMINS CHILE
Komatsu Cummins in Peru has extended its offering with the acquisition of Joy Global and is present on the majority of mine sites in the country.
Peter Bradford
MD AND CEO, INDEPENDENCE GROUP (IGO)
Independence Group outlines its current projects in Western Australia and its plans going forwards.
Víctor Gobitz
PRESIDENT, PERUVIAN INSTITUTE OF MINING ENGINEERS (IIMP)
The President of Peru’s Institute of Mining Engineers addresses the challenges of perception that the mining industry faces.
Liam Twigger
MANAGING DIRECTOR, PCF CAPITAL GROUP
PCF Capital Group describes the investment trends currently affecting the Australian mining industry.
Felipe Malbran
VP OF EXPLORATION, TRIMETALS MINING
Under its new name, TriMetals is bringing forth projects in North and South America with a focus on copper in Chile.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
